Table 3.
Risk Management Recommendations | N (%) |
---|---|
Monogenic Hereditary Related Recommendations | 597 (31.6%) |
Genetic counseling for hereditary cardiac syndromes | 107 (5.7%) |
Genetic counseling for hereditary cancer syndromes [26–29] | 395 (20.1%) |
Genetic counseling for hereditary thrombophilia [30] | 165 (8.7% |
Familial hypercholesterolemia testing [31] | 66 (3.4%) |
Hemochromatosis iron studies and genetic testing [32] | 3 (0.2%) |
Wilson’s disease genetic testing [33] | 11 (0.6%) |
Alpha 1 anti-trypsinase deficiency genetic testing [34] | 11 (0.6%) |
Familial Cancer Related Recommendations | 508 (26.9%) |
Ovarian cancer screening discussion [35] | 32 (1.7%) |
Breast MRI screening [5] | 58 (3.2%) |
Breast cancer chemoprevention [36] | 109 (6%) |
Colonoscopy screening starting age < 50 and/or more frequently [37, 38] | 241 (13.1%) |
Common Chronic Disease Related Recommendations | 1059 (56.1%) |
Aspirin for stroke prevention [39] | 67 (3.6%) |
Diabetes screening | 858 (45.4%) |
Abdominal Aortic Aneurysm screening [40, 41] | 389 (20.6%) |
Calcium scoring CT for further cardiovascular risk stratification [4] | 11 (0.6%) |
Lung cancer screening [42] | 45 (2.4%) |
Because participants could receive more than one recommendation, percentages in the value column do not sum to 100